[HTML][HTML] 托珠单抗治疗COVID-19 导致继发感染风险的Meta 分析
罗娅， 余彦廷， 张雪， 王重娟 - 昆明医科大学学报, 2024 - kyxuebao.kmmu.edu.cn
… basis for the safety of tocilizumab in patients with COVID-19. … study of treating COVID-19 with
tocilizumab from December 19, … should be carefully evaluated before clinical administration. …
tocilizumab from December 19, … should be carefully evaluated before clinical administration. …
在2019 冠状病毒病暴发流行期间感染并住院治疗的肾移植受者的临床特征与预后: 一项中国单中心队列研究
D LV, X XIE, Q YANG, Z CHEN, G LIU… - Journal of Zhejiang …, 2024 - jzus.zju.edu.cn
… of hospitalized kidney transplant recipients with COVID-19 infection in … Forty-eight (14.8%)
patients were treated with tocilizumab … The administration of immunomodulators or the late …
patients were treated with tocilizumab … The administration of immunomodulators or the late …
间充质干细胞用于COVID-19 相关脑卒中的治疗
M Rawat, C Ng, E Khan, RA Shah, S Ashfaq… - 中国神经再生研究 …, 2023 - sjzsyj.com.cn
… A study involving 21 severely ill COVID-19 patients showed that tocilizumab quickly
reduced their fever and inflammation and normalized peripheral blood T cell counts in most …
reduced their fever and inflammation and normalized peripheral blood T cell counts in most …
[HTML][HTML] 血浆置换和托珠单抗治疗六例2019 冠状病毒病(COVID-19) 重型患者临床分析
LUO Song, Y Lijuan, W Chun… - Journal of Zhejiang …, 2020 - ncbi.nlm.nih.gov
… Six patients with severe COVID-19 admitted in First Affiliated … Three patients were
treated with plasma exchange and three patients were treated with tocilizumab. The effect on …
treated with plasma exchange and three patients were treated with tocilizumab. The effect on …
2020 年《 系统性硬化症和COVID-19 大流行: 世界硬皮病基金会对患者管理的初步建议》 解读
崔洁涵， 杨林， 汪晓平， 何晶晶， 彭晓欣， 冯星， 马隽… - 中国全科医学, 2021 - chinagp.net
… more options for clinical management of these patients. [Key … in the treatment of patients
admitted to hospital with COVID-19:an … treatment of severe COVID-19 patients with tocilizumab[J].…
admitted to hospital with COVID-19:an … treatment of severe COVID-19 patients with tocilizumab[J].…
[HTML][HTML] 生物制剂在儿童感染SARS-CoV-2 后多系统炎症综合征的应用研究进展
崔涵雨， 胡长平 - Chinese Journal of Contemporary Pediatrics, 2022 - ncbi.nlm.nih.gov
… tocilizumab, and TNF-α receptor antagonist infliximab, can be used as an option for
critically ill patients… 2，SARS-CoV-2）引起的新型冠状病毒肺炎（coronavirus disease 2019，COVID-19）…
critically ill patients… 2，SARS-CoV-2）引起的新型冠状病毒肺炎（coronavirus disease 2019，COVID-19）…
重型新型冠状病毒肺炎患者临床特征及诊治分析
涂雄文， 全斌， 程玉生， 杨江华， 陆志伟 - 热带病与寄生虫学, 2020 - rdbzz.com
… reviewed in patients with severe COVID-19 diagnosed and treated in our hospital between
… received convalescent plasma infusion, and another one was given Tocilizumab therapy. …
… received convalescent plasma infusion, and another one was given Tocilizumab therapy. …
COVID-19 与低钠血症
梁思宇， 陈适， 潘慧 - 基础医学与临床 - journal11.magtechjournal.com
… related to poor outcomes in the management of COVID-19. … 接受IL-6抑制剂托珠单抗(tocilizumab)
治疗的患者在48 h后血钠… cases during hospitalization among patients with COVID19 in …
治疗的患者在48 h后血钠… cases during hospitalization among patients with COVID19 in …
COVID-19 患者使用靶向IL-6 药物的不良事件分析——基于FAERS 数据库.
卞叶萍， 邓晓静， 吴玲， 徐剑 - Practical Pharmacy & Clinical …, 2023 - search.ebscohost.com
… titis associated with tocilizumab use using the United States Food and Drug Administration
Adverse Event Reporting System database[J]. Sci Repꎬ2021ꎬ11(1):18818. [11] 左玮ꎬ刘容吉…
Adverse Event Reporting System database[J]. Sci Repꎬ2021ꎬ11(1):18818. [11] 左玮ꎬ刘容吉…
[PDF][PDF] 新型冠状病毒肺炎的抗病毒治疗进展
石浩川， 潘蕾 - 中国现代医药杂志, 2024 - zgxdyyzz.com.cn
… Oral azvudine for hospitalised patients with COVID-19 and pre-existing conditions:a …
Tocilizumab in patients admitted … Early administration of tocilizumab in hospitalized COVID-19 …
Tocilizumab in patients admitted … Early administration of tocilizumab in hospitalized COVID-19 …